Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for EssilorLuxottica Unsponsored ADR (ESLOY : OTC)

• Company Description    EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. Number of Employees: 203,791

• Price / Volume Information    Yesterday's Closing Price: $100.48 Daily Weekly Monthly 20 Day Moving Average: 127,763 shares Shares Outstanding: 926.58 (millions) Market Capitalization: $93,102.66 (millions) Beta: 0.94 52 Week High: $186.81 52 Week Low: $96.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -17.32% -21.42% 12 Week -26.47% -31.89% Year To Date -36.57% -42.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 147 rue de Paris Charenton-le-Pont - Paris,I0 94220 FRA ph: 33-01-49-77-42-24 fax: 33-1-49-77-43-24 ir@essilorluxottica.com http://www.essilorluxottica.com

• General Corporate Information    Officers Francesco Milleri - Chief Executive Officer and Chairman Paul du Saillant - Deputy Chief Executive Officer Jean-Luc Biamonti - Chairman Marie-Christine Coisne-Roquette - Director Jose Gonzalo - Director Peer Information EssilorLuxottica Unsponsored ADR (BJCT) EssilorLuxottica Unsponsored ADR (CADMQ) EssilorLuxottica Unsponsored ADR (APNO) EssilorLuxottica Unsponsored ADR (UPDC) EssilorLuxottica Unsponsored ADR (IMTIQ) EssilorLuxottica Unsponsored ADR (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 297284200 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 05/13/26 Share - Related Items Shares Outstanding: 926.58 Most Recent Split Date: (:1) Beta: 0.94 Market Capitalization: $93,102.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.68% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $1.69 Current Fiscal Year EPS Consensus Estimate: $4.34 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 14.17% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/13/26

• Fundamental Ratios P/E Current FY Estimate: 23.15 Trailing 12 Months: - PEG Ratio: 1.63 Price Ratios Price/Book: 2.08 Price/Cash Flow: 13.13 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 0.99 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - 0.70 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - 11.21 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 48.22 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - 3.25 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.17 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 14.71 09/30/25 - -

Powered by Zacks Investment Research ©